American Century Companies Inc Celldex Therapeutics, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 415,364 shares of CLDX stock, worth $10.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

415,364

Previous 416,000 0.15%

Holding current value

$10.8 Million

Previous $15.4 Million 8.36%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$32.06 - $44.56 $20,390 - $28,340	-636 Reduced 0.15%	415,364 $14.1 Million
Q2 2024 Aug 07, 2024	BUY	$32.76 - $42.56 $7.66 Million - $9.96 Million	233,928 Added 128.48%	416,000 $15.4 Million
Q1 2024 May 14, 2024	BUY	$35.22 - $51.88 $740,359 - $1.09 Million	21,021 Added 13.05%	182,072 $7.64 Million
Q4 2023 Feb 13, 2024	BUY	$22.61 - $40.65 $3.64 Million - $6.55 Million	161,051 New	161,051 $6.39 Million
Q3 2023 Nov 13, 2023	BUY	$25.45 - $37.46 $585 - $861	23 Added 0.01%	160,860 $4.43 Million
Q2 2023 Aug 14, 2023	SELL	$30.29 - $38.28 $148,148 - $187,227	-4,891 Reduced 2.95%	160,837 $5.46 Million
Q1 2023 May 11, 2023	SELL	$34.78 - $47.43 $1.12 Million - $1.53 Million	-32,233 Reduced 16.28%	165,728 $5.96 Million
Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $66,644 - $108,866	2,399 Added 1.23%	197,961 $8.82 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $16,412 - $27,163	-723 Reduced 0.37%	195,562 $5.5 Million
Q2 2022 Aug 12, 2022	BUY	$20.5 - $37.33 $271,994 - $495,294	13,268 Added 7.25%	196,285 $5.29 Million
Q1 2022 May 11, 2022	SELL	$27.64 - $39.32 $39,082 - $55,598	-1,414 Reduced 0.77%	183,017 $6.23 Million
Q4 2021 Feb 07, 2022	BUY	$35.68 - $56.27 $6.58 Million - $10.4 Million	184,431 New	184,431 $7.13 Million

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Celldex Therapeutics, Inc. Transaction History